Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1954 1
1955 2
1957 3
1958 1
1959 1
1963 1
1967 1
1970 1
1971 5
1972 3
1973 5
1974 2
1975 4
1976 1
1977 4
1978 2
1979 1
1980 3
1981 1
1982 4
1983 6
1984 4
1985 6
1986 9
1987 10
1988 5
1989 12
1990 10
1991 9
1992 12
1993 17
1994 10
1995 6
1996 17
1997 8
1998 12
1999 16
2000 12
2001 12
2002 10
2003 13
2004 11
2005 22
2006 24
2007 22
2008 18
2009 39
2010 28
2011 27
2012 31
2013 42
2014 119
2015 159
2016 162
2017 202
2018 237
2019 246
2020 346
2021 390
2022 361
2023 421
2024 215

Text availability

Article attribute

Article type

Publication date

Search Results

2,975 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Strength of association between comorbidities and asthma: a meta-analysis.
Rogliani P, Laitano R, Ora J, Beasley R, Calzetta L. Rogliani P, et al. Eur Respir Rev. 2023 Mar 8;32(167):220202. doi: 10.1183/16000617.0202-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36889783 Free PMC article. Review.
A pairwise meta-analysis was performed and the strength of association calculated by anchoring odds ratios and 95% confidence intervals with the rate of comorbidities in nonasthma populations via Cohen's d method. Cohen's d=0.2, 0.5 and 0.8 were cut-of …
A pairwise meta-analysis was performed and the strength of association calculated by anchoring odds ratios and 95% confidence intervals with …
A brief diet intervention can reduce symptoms of depression in young adults - A randomised controlled trial.
Francis HM, Stevenson RJ, Chambers JR, Gupta D, Newey B, Lim CK. Francis HM, et al. PLoS One. 2019 Oct 9;14(10):e0222768. doi: 10.1371/journal.pone.0222768. eCollection 2019. PLoS One. 2019. PMID: 31596866 Free PMC article. Clinical Trial.
The primary and secondary outcome measures assessed at baseline and after the intervention included symptoms of depression (Centre for Epidemiological Studies Depression Scale; CESD-R; and Depression Anxiety and Stress Scale- 21 depression subscale; DASS-21-D), curr …
The primary and secondary outcome measures assessed at baseline and after the intervention included symptoms of depression (Centre for Epide …
Reply to S. Chakrabarti et al, R. Cohen et al, and D.C. Guven.
Gray R, Seymour M, Magill L, Handley K, Quirke P, West N, Morton D. Gray R, et al. J Clin Oncol. 2023 Oct 20;41(30):4823-4824. doi: 10.1200/JCO.23.00694. Epub 2023 Jul 18. J Clin Oncol. 2023. PMID: 37463406 No abstract available.
Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
Kamagata K, Andica C, Takabayashi K, Saito Y, Taoka T, Nozaki H, Kikuta J, Fujita S, Hagiwara A, Kamiya K, Wada A, Akashi T, Sano K, Nishizawa M, Hori M, Naganawa S, Aoki S; Alzheimer's Disease Neuroimaging Initiative. Kamagata K, et al. Neurology. 2022 Dec 12;99(24):e2648-e2660. doi: 10.1212/WNL.0000000000201300. Neurology. 2022. PMID: 36123122 Free PMC article.

Patients with AD had significantly higher total, WM, and basal ganglia PVSVF (Cohen d = 1.15-1.48; p < 0.001) and FW-WM (Cohen d = 0.73; p < 0.05) and a lower ALPS index (Cohen d = 0.63; p < 0.05) than healthy controls. Meanwhile

Patients with AD had significantly higher total, WM, and basal ganglia PVSVF (Cohen d = 1.15-1.48; p < 0.001) and FW-WM (

Robot-assisted gait training with auditory and visual cues in Parkinson's disease: A randomized controlled trial.
Kim H, Kim E, Yun SJ, Kang MG, Shin HI, Oh BM, Seo HG. Kim H, et al. Ann Phys Rehabil Med. 2022 May;65(3):101620. doi: 10.1016/j.rehab.2021.101620. Epub 2022 Feb 23. Ann Phys Rehabil Med. 2022. PMID: 34896605 Free article. Clinical Trial.
The groups did not significantly differ on the 10mWT (T0-T1, p = 0.726, Cohen's d = 0.133; T0-T2, p = 0.778, Cohen's d = 0.121). We observed a significant time-by-group interaction (F = 3.236, p = 0.045) for cognitive dual-task interference, controllin …
The groups did not significantly differ on the 10mWT (T0-T1, p = 0.726, Cohen's d = 0.133; T0-T2, p = 0.778, Cohen's …
Corrigendum.
[No authors listed] [No authors listed] Psychol Sci. 2017 Mar;28(3):399-402. doi: 10.1177/0956797617690343. Epub 2017 Feb 1. Psychol Sci. 2017. PMID: 28192038
Original article: Cohen, A. O., Breiner, K., Steinberg, L., Bonnie, R. J., Scott, E. S., Taylor-Thompson, K. A., Rudolf, M. D., Chein, J., Richeson, J. A., Heller, A. S., Silverman, M. R., Dellarco, D. ...
Original article: Cohen, A. O., Breiner, K., Steinberg, L., Bonnie, R. J., Scott, E. S., Taylor-Thompson, K. A., Rudolf, M. …
Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex.
Strickson S, Houslay KF, Negri VA, Ohne Y, Ottosson T, Dodd RB, Huntington CC, Baker T, Li J, Stephenson KE, O'Connor AJ, Sagawe JS, Killick H, Moore T, Rees DG, Koch S, Sanden C, Wang Y, Gubbins E, Ghaedi M, Kolbeck R, Saumyaa S, Erjefält JS, Sims GP, Humbles AA, Scott IC, Romero Ros X, Cohen ES. Strickson S, et al. Eur Respir J. 2023 Sep 28;62(3):2202210. doi: 10.1183/13993003.02210-2022. Print 2023 Sep. Eur Respir J. 2023. PMID: 37442582 Free PMC article.
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction.
England E, Rees DG, Scott IC, Carmen S, Chan DTY, Chaillan Huntington CE, Houslay KF, Erngren T, Penney M, Majithiya JB, Rapley L, Sims DA, Hollins C, Hinchy EC, Strain MD, Kemp BP, Corkill DJ, May RD, Vousden KA, Butler RJ, Mustelin T, Vaughan TJ, Lowe DC, Colley C, Cohen ES. England E, et al. Sci Rep. 2023 Jun 17;13(1):9825. doi: 10.1038/s41598-023-36642-y. Sci Rep. 2023. PMID: 37330528 Free PMC article.
Project D.A.R.E. outcome effectiveness revisited.
West SL, O'Neal KK. West SL, et al. Am J Public Health. 2004 Jun;94(6):1027-9. doi: 10.2105/ajph.94.6.1027. Am J Public Health. 2004. PMID: 15249310 Free PMC article.
METHODS: We used meta-analytic techniques to create an overall effect size for D.A.R.E. outcome evaluations reported in scientific journals. RESULTS: The overall weighted effect size for the included D.A.R.E. studies was extremely small (correlation co …
METHODS: We used meta-analytic techniques to create an overall effect size for D.A.R.E. outcome evaluations reported in scient …
2,975 results